Status:
COMPLETED
Safety and Efficacy of Zinc Supplementation in HIV-1-Infected Children in South Africa
Lead Sponsor:
Johns Hopkins Bloomberg School of Public Health
Collaborating Sponsors:
United States Agency for International Development (USAID)
University of KwaZulu
Conditions:
HIV Infections
Eligibility:
All Genders
6-60 years
Phase:
PHASE2
Brief Summary
The goal of the study is to rule out a harmful effect of zinc supplementation in HIV-1-infected children. The null hypothesis is that zinc supplementation will increase plasma HIV RNA levels.
Detailed Description
A randomized, double-blind, placebo-controlled equivalence trial of zinc supplementation was conducted at Grey's Hospital in Pietermaritzburg, South Africa. Ninety-six HIV-1-infected children were ran...
Eligibility Criteria
Inclusion
- HIV-infection
- 6 to 60 months of age
- Not receiving antiretroviral therapy
- Cared for as outpatients at Grey's Hospital
Exclusion
- Receiving antiretroviral therapy
Key Trial Info
Start Date :
March 1 2003
Trial Type :
INTERVENTIONAL
End Date :
September 1 2004
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00138047
Start Date
March 1 2003
End Date
September 1 2004
Last Update
December 5 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grey's Hospital
Pietermaritzburg, South Africa